Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06152575 MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranat… |
Elranatamab | Cancer | Phase 3 | RECRUITING | En attente / non publié | Pfizer | United States, Argentina, Australia, Belgium, Brazil,… | 2024-02-08 → 2027-12-30 | Ouvrir |
| NCT06685848 Comparison of Hemanext ONE® System and Conventional Red Blood Cell Tran… |
Hemanext ONE system | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Hemanext | United States, Norway · Duke University Health System… | 2024-11-29 → 2028-08 | Ouvrir |
| NCT07763210 Lazarus: IT Therapy for ICANS |
Hydrocortisone | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Royal Brompton & Harefield NHS Fo… | United States · Vanderbilt University/Ingram Cancer C… | 2026-10-01 → 2030-10-01 | Ouvrir |
| NCT06459024 IMPACT STREAM — Master Framework For Relapse or Refractory Acute Myeloi… |
IMPACT STREAM — Master Framework … | Cancer | À vérifier | RECRUITING | En attente / non publié | Istituto Romagnolo per lo Studio … | Germany, Italy, Lithuania, Poland, Romania, Spain · A… | 2024-06-28 → 2032-07 | Ouvrir |
| NCT07425054 CHART-AC — ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Tr… |
HPV ctDNA Response based radiation | Cancer | Phase 2 | RECRUITING | En attente / non publié | Jennifer Dorth | United States · Case Comprehensive Cancer Center, Cle… | 2026-06-19 → 2029-01 | Ouvrir |
| NCT06878274 RESCUE — Post-operative Radiotherapy After Neodjuvant Chemo-immunothera… |
Post-operative radiotherapy | Cancer | Phase 2 | RECRUITING | En attente / non publié | Centre hospitalier de l'Universit… | Canada · Centre Hospitalier de l'Universite de Montre… | 2026-01-29 → 2032-02 | Ouvrir |
| NCT05758116 Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Che… |
Tislelizumab | Cancer | Phase 2 | COMPLETED | En attente / non publié | University Health Network, Toronto | China · Peking University Cancer Hospital and Institu… | 2022-07-07 → 2026-06-30 | Ouvrir |
| NCT05748171 A Study to Learn More About the Study Medicine Called Inotuzumab Ozogam… |
Inotuzumab ozogamicin | Cancer | Phase 2 | RECRUITING | En attente / non publié | Pfizer | Austria, Belgium, Czechia, Denmark, Finland, France, … | 2023-05-17 → 2036-05-25 | Ouvrir |
| NCT03502733 Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Pati… |
Biopsy Procedure | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Cancer Institute Development… | 2018-08-14 → 2027-08-01 | Ouvrir |
| NCT05538130 A Study to Learn About the Study Medicine Called PF-07799544 as Monothe… |
PF-07799544 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Pfizer | United States, Australia, Brazil, Canada, China, Isra… | 2022-11-30 → 2029-06-18 | Ouvrir |
| NCT07318558 TroFuse-021 — A Clinical Trial of Sac-TMT in People With Non-HRD Positi… |
Sacituzumab Tirumotecan | Cancer | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Austria, Belgium… | 2026-02-16 → 2033-02-25 | Ouvrir |
| NCT07747363 Community-Based Screening for Chronic Kidney Disease |
Community-Based Screening for Chr… | Hypertension | Non applicable | COMPLETED | En attente / non publié | University of Texas at Austin | United States · Dell Medical School - The University … | 2006-06-21 → 2024-05-10 | Ouvrir |
| NCT07117695 DUKE PREVENT — Duke Cardiometabolic Prevention Clinic's Impact on High-… |
DUKE PREVENT — Duke Cardiometabol… | Hypertension | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Duke University | United States · Duke University Medical Center, Durha… | 2026-09-02 → 2028-01-27 | Ouvrir |
| NCT07748975 DETAIL — Decode the Environment Variation of Targeted Aldosterone Induc… |
Medication | Hypertension | Non applicable | NOT_YET_RECRUITING | En attente / non publié | DejthidaNathaphong | Thailand · Investigation Center, Vadhana, Thailand | 2026-08-10 → 2028-02-05 | Ouvrir |
| NCT02055209 Genomics, Environmental Factors and Social Determinants of Cardiovascul… |
Genomics, Environmental Factors a… | Hypertension | À vérifier | COMPLETED | En attente / non publié | National Heart, Lung, and Blood I… | United States · National Institutes of Health Clinica… | 2014-07-23 → 2024-03-08 | Ouvrir |
| NCT07751445 Unilateral and Bilateral Resistance Training in Hypertension |
Unilateral and Bilateral Resistan… | Hypertension | Non applicable | RECRUITING | En attente / non publié | Hacettepe University | Turkey (Türkiye) · Munzur University Faculty of Healt… | 2026-06-22 → 2026-10-01 | Ouvrir |
| NCT00001853 Diabetes and Heart Disease Risk in Blacks |
Diabetes and Heart Disease Risk i… | Hypertension | À vérifier | RECRUITING | En attente / non publié | National Institute of Diabetes an… | United States · National Institutes of Health Clinica… | 1998-10-21 | Ouvrir |
| NCT04236518 Nutritional Transitions to More Plant Proteins and Less Animal Proteins… |
Nutritional Transitions to More P… | Hypertension | Non applicable | COMPLETED | En attente / non publié | University Hospital, Clermont-Fer… | France · CHU de Clermont-Ferrand, Clermont-Ferrand, F… | 2020-08-27 → 2022-08-05 | Ouvrir |
| NCT07752082 The Impact of Intra-Abdominal Pressure on Mortality and Morbidity in Pa… |
The Impact of Intra-Abdominal Pre… | Hypertension | À vérifier | COMPLETED | En attente / non publié | Bursa Yuksek Ihtisas Training and… | Turkey (Türkiye) · Bursa Yuksek Ihtisas Research and … | 2023-03-02 → 2024-03-10 | Ouvrir |
| NCT07753681 PEN Plus — Domestication and Implementation of the PEN-Plus Clinical Mo… |
Supportive treatment | Hypertension | À vérifier | RECRUITING | En attente / non publié | Centre for Infectious Disease Res… | Zambia · Matero First Level Hospital, Lusaka, Zambia | 2022-08-08 → 2027-09-30 | Ouvrir |
| NCT07064473 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together W… |
Vicadrostat | Hypertension | Phase 3 | RECRUITING | En attente / non publié | Boehringer Ingelheim | United States, Argentina, Australia, Austria, Belgium… | 2025-07-22 → 2029-12-21 | Ouvrir |
| NCT01986088 Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple… |
Eletriptan 40 mg | Migraine | Phase 3 | COMPLETED | En attente / non publié | Pfizer's Upjohn has merged with M… | Non communiqué | 1996-11 → 1998-01 | Ouvrir |
| NCT01978496 Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of … |
Eletriptan 20 mg | Migraine | Phase 3 | COMPLETED | En attente / non publié | Pfizer's Upjohn has merged with M… | Non communiqué | 1996-07 → 1997-12 | Ouvrir |
| NCT01986270 Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan … |
Eletriptan 40 mg | Migraine | Phase 3 | COMPLETED | En attente / non publié | Pfizer's Upjohn has merged with M… | Non communiqué | 1996-12 → 1998-01 | Ouvrir |
| NCT02856802 An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg) |
Sumatriptan 10 mg Nasal Spray | Migraine | Phase 2 | COMPLETED | En attente / non publié | Upsher-Smith Laboratories | United States · Site 02, Albuquerque, United States |… | 2016-07-11 → 2017-02-10 | Ouvrir |